2024-01-10
Financial Times
Demis Hassabis, chief of DeepMind spinout Isomorphic Labs, believes the company would halve drug discovery times after inking deals with Eli Lilly and Novartis
Chief of Google's AI unit and Isomorphic Labs spells out targets following $3bn Eli Lilly-Novartis partnerships X: @kymawhite . Forums: Slashdot X: Kimberly White / @kymawhite : Thanks to the team at ...
Loading articles...